共 51 条
[1]
Helbig G(2014)Advances in the diagnosis and treatment of eosinophilia Curr Opin Hematol 21 3-7
[2]
Nutman TB(2007)Evaluation and differential diagnosis of marked, persistent eosinophilia Immunol Allergy Clin North Am 27 529-49
[3]
Weller PF(1994)The idiopathic hypereosinophilic syndrome Blood 83 2759-79
[4]
Bubley GJ(1996)Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis Gastroenterology 110 768-74
[5]
Desreumaux P(2013)Testing for drug hypersensitivity syndromes Clin Biochem Rev 34 15-38
[6]
Bloget F(1992)Phase I trial of Taxotere: five-day schedule J Natl Cancer Inst 84 1781-8
[7]
Seguy D(2015)Re-visiting hypersensitivity reactions to taxanes: a comprehensive review Clin Rev Allergy Immunol 49 177-91
[8]
Capron M(2011)Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS J Exp Clin Cancer Res 30 93-53 e8
[9]
Cortot A(2010)Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma J Allergy Clin Immunol 125 1046-904
[10]
Colombel JF(1995)Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma J Exp Med 182 1897-12